Free Medications for the UnemployedDifficult economic times call for the adoption of drastic measures by people and corporations alike. Recent unemployment rates show that they're just below the 9% mark, which is a frightful figure in relation to the economic outlook of the United States. Unemployment generates a slower economy, which in turn generates more unemployment, which results in increasing homelessness.
Most people, when thinking about homelessness, imagine a group of people who lack a roof over their heads and enough food to eat, which is partly true. However, the issue goes beyond that. Homelessness is also a major killer of people in the United States, since it prevents them from acquiring the necessary medications to treat their various physical conditions and illnesses, a fact often overlooked by most.
Pfizer, the pharmaceutical giant, stepped up to the plate in this regard with a program, which provides unemployed people (3 months or more without a job) with basic medications. They distribute more than 70 of their meds to people who meet the job loss and homelessness criteria, and will provide them with free medications for up to one year.
Applicants must also prove that they were taking that particular medication at least 3 months before losing their jobs.
Some of the medications the Pfizer is offering for free include, cholesterol-lowering medication Lipitor, antidepressant Zoloft, and impotency treatment Viagra. Pfizer considers those medication to be treatments for chronic conditions, which are suffered by large segments of the population.
Although income prior to becoming unemployed is not an issue, Pfizer said that those who become employed again or regain prescription drug coverage will have to start buying the medications again.
According to marketing experts, this is a win-win situation for everyone: the unemployed and homeless get their meds for free, and Pfizer generates customer loyalty, and in the process, even gain some word-of-mouth converts that used to buy Cialis, or other similar medications from the competition.